BR0111975A - Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator - Google Patents
Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fatorInfo
- Publication number
- BR0111975A BR0111975A BR0111975-3A BR0111975A BR0111975A BR 0111975 A BR0111975 A BR 0111975A BR 0111975 A BR0111975 A BR 0111975A BR 0111975 A BR0111975 A BR 0111975A
- Authority
- BR
- Brazil
- Prior art keywords
- prpsc
- factor
- encephalopathies
- sample
- processes
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
"FATOR, COMPOSIçãO, VEìCULO, LIGANDO, KITS DE DIAGNóSTICOS, PROCESSOS PARA DETECTAR UMA PRPSC EM UMA AMOSTRA, E PARA REMOVER PRPSC DE MATERIAL BIOLóGICO, MéTODO PARA DIAGNOSTICAR ENCEFALOPATIAS ESPONGIFORMES HUMANAS TRANSMISSìVEIS E ENCEFALOPATIAS DE PRìONS DE ANIMAIS, E, USO DE UM FATOR". São apresentados métodos e ferramentas para a concentração e detecção, bem como quantificação, de proteínas patológicas de príons, bem como agentes a serem usados na dita detecção e/ou na prevenção ou tratamento de doenças de príons. Ditos agentes são fatores com atividades de ligação de príons observadas no soro sang³íneo e no plasma sang³íneo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2000/000849 WO2001023425A1 (en) | 1999-09-28 | 2000-06-26 | Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
PCT/EP2001/003481 WO2002000713A1 (en) | 2000-06-26 | 2001-03-27 | Prion-binding activity in serum and plasma determined as plasminogen and fibrinogen |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0111975A true BR0111975A (pt) | 2003-07-01 |
Family
ID=11003939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0111975-3A BR0111975A (pt) | 2000-06-26 | 2001-03-27 | Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1294759A1 (pt) |
JP (1) | JP2004501626A (pt) |
AU (1) | AU2001250406A1 (pt) |
BR (1) | BR0111975A (pt) |
CA (1) | CA2413742A1 (pt) |
WO (1) | WO2002000713A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100526884C (zh) * | 2002-02-28 | 2009-08-12 | 米克罗森拜奥菲哲有限公司 | 病理形式朊病毒蛋白的结合 |
DE10230141B4 (de) * | 2002-07-04 | 2004-07-15 | Priontype Gmbh | Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) |
US7482172B2 (en) | 2005-09-19 | 2009-01-27 | Ortho-Clinical Diagnostics, Inc. | Peptides for discrimination of prions |
AU2005209592B2 (en) | 2004-09-30 | 2012-07-12 | Ortho-Clinical Diagnostics, Inc. | Peptides for discrimination of prions |
AU2006322247A1 (en) * | 2005-12-08 | 2007-06-14 | South Dakota State University | Methods of in vitro propagation and detection of infectious prion |
FR2940446A1 (fr) * | 2008-12-22 | 2010-06-25 | Lfb Biotechnologies | Procede de detection d'une infection par prion |
FR2973114A1 (fr) * | 2011-03-21 | 2012-09-28 | Ets Francais Du Sang | Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc |
EP3064757B1 (en) | 2015-03-05 | 2018-11-14 | Continental Automotive GmbH | Method for manufacturing an injector for injecting fluid and injector for injecting fluid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19925073C2 (de) * | 1999-06-01 | 2001-07-19 | Stefan Weiss | Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung |
AU783484B2 (en) * | 1999-06-23 | 2005-11-03 | Thallion Pharmaceuticals Inc. | Prion protein peptides and uses thereof |
CA2385743A1 (en) * | 1999-09-28 | 2001-04-05 | Universitat Zurich | Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
-
2001
- 2001-03-27 EP EP01923701A patent/EP1294759A1/en not_active Withdrawn
- 2001-03-27 AU AU2001250406A patent/AU2001250406A1/en not_active Abandoned
- 2001-03-27 BR BR0111975-3A patent/BR0111975A/pt not_active IP Right Cessation
- 2001-03-27 JP JP2002505835A patent/JP2004501626A/ja active Pending
- 2001-03-27 WO PCT/EP2001/003481 patent/WO2002000713A1/en not_active Application Discontinuation
- 2001-03-27 CA CA002413742A patent/CA2413742A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2001250406A1 (en) | 2002-01-08 |
CA2413742A1 (en) | 2002-01-03 |
EP1294759A1 (en) | 2003-03-26 |
WO2002000713A1 (en) | 2002-01-03 |
JP2004501626A (ja) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004022150D1 (de) | Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung | |
WO2003070894A3 (en) | A non-invasive diagnostic test utilizing histone modification markers | |
DE59903915D1 (de) | Verfahren zur frühen diagnose von carcinomen | |
DE602005024810D1 (de) | Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung | |
Procopio et al. | Exploring biological and geological age-related changes through variations in intra-and intertooth proteomes of ancient dentine | |
ATE461449T1 (de) | Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben | |
AU6279399A (en) | Methods and materials for detection and measurement of free radical damage | |
ATE393237T1 (de) | Mittel und verfahren zur in-vitro-bestimmung von camp | |
WO2006084299A8 (en) | Method for evaluating the allergen sensitivity of an individual | |
BR0111975A (pt) | Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator | |
WO2003042659A3 (en) | Rapid prion-detection assay | |
WO2003028543A3 (en) | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
AU2003259222A1 (en) | Method of diagnosing alzheimer's disease | |
BR9804648A (pt) | Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos. | |
US20110160434A1 (en) | Fibromyalgia test method | |
AR058510A1 (es) | Procedimiento de diagnostico de enfermedades hepaticas y de muestreo de moleculas para el tratamiento de estas enfermedades | |
DE60138192D1 (de) | Verfahren zur quantifizierung der akt-protein-expression | |
Meli et al. | Serum pentosidine as an indicator of Alzheimer's disease | |
WO2002016947A3 (en) | Methods and kits for separation and detection of proteins in biological samples | |
ATE472102T1 (de) | Verfahren zur vorhersage von anomalien des lipidmetabolismus | |
ATE395601T1 (de) | Verfahren zum vorhersagen von preeclampsia und anderen krankheiten | |
RS20060255A (en) | Quick test for the diagnosis of alzheimer's disease | |
WO2005115394A3 (en) | Prenyl-electrostatic switch, and methods of use | |
JP6017724B1 (ja) | 十二指腸液試料の膵液由来成分検出用試料としての適性評価方法 | |
WO2005049791A3 (en) | Identification of reagents for the diagnosis and study of francisella |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008. |